Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients.
A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation.
Application of q-Space Diffusion MRI for the Visualization of White Matter.
Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.
Cambridge Healthtech Institute's Third Annual Anti-inflammatories: small Molecules Meeting, April 17(th) - 18(th) 2012, San Diego, USA.
Transverse myelitis with Brown-Sèquard syndrome after H1N1 immunization.
Multiple sclerosis drug fingolimod receives new safety warnings related to cardiovascular risk.
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely.
Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Experience of gratitude, awe and beauty in life among patients with multiple sclerosis and psychiatric disorders.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Autoimmune diseases and reproductive aging.
Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review.
[Treatment of neuromyelitis optica].
Two demyelinating diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'.
CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System.

Pages